MedTrace Logo

Analyzes of Hemorrhagic Obstetric Patients Whose Were Used Fibrinogen

NCT03723200 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 56

Last updated 2018-10-30

No results posted yet for this study

Summary

The files of hemorrhagic obstetric patients undergoing surgery and followed in the intensive care unit and using Fibrinogen and blood products were included in the study between January 2015- September 2018 at the Anesthesiology and Reanimation Clinic of SBU Kanuni Sultan Süleyman Training and Research Hospital. Patients under 18 years of age were excluded from the study. In this study, ages, operation types, number of blood and products, the amount of fibrinogen, the results of the hemogram and bleeding parameters, the levels of fibrinogen, the duration of hospital stay and the intensive care unit were recorded.

Conditions

Interventions

OTHER

Fibrinogen and blood products

Fibrinogen and blood products

Sponsors & Collaborators

  • Kanuni Sultan Suleyman Training and Research Hospital

    lead OTHER

Principal Investigators

  • Ayca Sultan Sahin, MD · Kanuni Sultan Suleyman Education and Training Hospital

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-10-09
Primary Completion
2018-10-16
Completion
2018-10-24

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03723200 on ClinicalTrials.gov